Mezym F

Pancreatin, the active ingredient in Mezym F, is a digestive enzyme presented as a powder for oral solution use. It treats exocrine pancreatic insufficiency and related conditions in patients requiring pancreatic enzyme replacement therapy.

GNH USA supplies Mezym F as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mezym F (pancreatin) provides pancreatic enzyme replacement for disorders characterized by insufficient digestive enzyme production.

- Exocrine pancreatic insufficiency: improves digestion and nutrient absorption. - Cystic fibrosis: aids breakdown of fats, proteins, and carbohydrates to support nutritional status. - Chronic pancreatitis: compensates for reduced endogenous enzyme output to reduce steatorrhea. - Pancreatic enzyme replacement therapy: restores normal digestive function in patients lacking pancreatic secretions.

Adverse reactions may occur with any pancreatic enzyme preparation. Most are mild and reversible.

Common Side Effects: - Abdominal discomfort or cramping. - Flatulence or bloating. - Diarrhea or loose stools. - Nausea or mild vomiting. - Constipation. - Oily or fatty stools.

Serious or Rare Side Effects: - Allergic reactions such as rash, urticaria, or anaphylaxis. - Severe abdominal pain indicating possible pancreatitis. - Intestinal obstruction or blockage. - Respiratory distress or bronchospasm. - Significant elevation of serum amylase. - Unexplained weight loss despite therapy.

Use of Mezym F requires careful clinical monitoring and patient education.

- Dose individualization: adjust based on clinical response and stool fat content. - Monitor nutritional status: regularly assess weight, vitamin levels, and growth in children. - Assess for hypersensitivity: discontinue if signs of allergic reaction appear. - Administer with meals and snacks: ensures enzymes contact ingested food for optimal activity. - Avoid concurrent use of certain acid‑reducing agents without dose adjustment. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pancreatin may interact with other medications that affect gastric acidity or fat digestion.

Major Interactions (Avoid): - Proton pump inhibitors: can reduce enzyme activity and efficacy. - Antacids containing aluminum or magnesium: may bind enzymes and diminish their action. - Orlistat: interferes with fat digestion, potentially reducing the benefit of pancreatic enzymes.

Moderate Interactions (Monitor Closely): - H2‑blockers (e.g., ranitidine): may require enzyme dose increase. - Bile‑acid sequestrants (e.g., cholestyramine): can bind enzymes, lowering their availability. - High‑dose corticosteroids: may affect gastrointestinal absorption of enzymes.